Patent Assignment
Reel/Frame 023852/0595
Change of Name
Recorded: 2010-01-27
Pages: 29
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(200)
Methods of Synthesizing Benign Prostatic Hypertropic Agents and Their Intermediates
Patent:
5,237,061 →
Application:
07/264,652 →
Swelling Modulated Polymeric Drug Delivery Device
Patent:
5,120,548 →
Application:
07/433,056 →
Method for Introducing a 1,2 Double Bond into Azasteroids
Patent:
5,021,575 →
Application:
07/434,663 →
Calcium Channel Compositions and Methods
Patent:
5,386,025 →
Application:
07/482,384 →
Cloning Genes from Streptomyces Avermitilis for Avermectin Biosynthesis and the Methods for Their Use
Patent:
5,252,474 →
Application:
07/490,723 →
Antibiotic Agent Produced by the Cultivation of 2ALERION Microorganism in the Presence of Mannitol
Patent:
5,021,341 →
Application:
07/492,026 →
Dna and Mrna Encoding Human Neuronal Nicotinic Acetylcholine Receptor Compositions Cells Transformed with Same
Patent:
5,369,028 →
Application:
07/504,455 →
Arylation Process for Preparation of Chiral Catalysts for Ketone Redunction
Patent:
5,039,802 →
Application:
07/510,768 →
(S)-Alkyl 3-(Thien-2-Ylthio)Butyrate and Analogs and Synthesis Thereof
Patent:
4,968,814 →
Application:
07/510,806 →
Substituted Imidazo-Fused 6-Membered Heterocycles as Angiotensin Ii Antagonists
Patent:
5,332,744 →
Application:
07/516,286 →
Ortho-Lithiation Process for the Synthesis of 2-Substituted 1-(Tetrazol-5-Yl)Benzenes
Patent:
5,039,814 →
Application:
07/517,889 →
Avermectin Derivatives with a Spacer Inserted Between the Disaccharide and the Aglycone Useful as Antiparasitic Agents
Patent:
5,114,930 →
Application:
07/522,709 →
4-Alkylamino-6-(C3-5-Hydrocarbyl)Thieno(2,3-B)Thiopyran-2-Sulfonamide- 7, 7-Dioxides
Patent:
5,091,409 →
Application:
07/524,523 →
Process for Preparing 4-Amino-1-Hydroxybutylidene-1,1-Bisphosphonic Acid (Abp) or Salts Thereof
Patent:
5,019,651 →
Application:
07/540,997 →
Process for Preparing an Angiotensin Ii Antagonist
Patent:
5,089,626 →
Application:
07/571,398 →
Trialkylsilyl Trifluoromethanesulfonate Mediated Alpha-Methylenic Carbon Functionalization of 4-Aza-5ALPHA-Androstan-3-One Steroids
Patent:
5,091,534 →
Application:
07/572,811 →
Process for Iodinating or Brominating the Alpha-Methylenic Carbon of a Secondary Amide
Patent:
5,120,847 →
Application:
07/572,920 →
New Diphosphonate Intermediate for Preparing an Antihypercalcemic Agent
Patent:
5,039,819 →
Application:
07/584,322 →
Child Resistant Unit Dose Package
Patent:
5,082,114 →
Application:
07/597,644 →
4"-And 4'-Alkylthio Avermectin Derivatives
Patent:
5,208,222 →
Application:
07/676,626 →
Treatment of Renal Diseases with Ace Inhibitors
Patent:
5,238,924 →
Application:
07/721,790 →
Chiral Boron Catalysts for Reduction of Ketones and Process for Their Preparation
Patent:
5,189,177 →
Application:
07/730,316 →
Process for Preparing an Antihypercalcemic Agent
Patent:
5,159,108 →
Application:
07/742,142 →
Antibiotic Agent
Patent:
5,194,377 →
Application:
07/742,968 →
Antibiotic Agent
Patent:
5,202,309 →
Application:
07/749,633 →
Process for Crystalline Cyclic Lipopeptides
Patent:
5,336,756 →
Application:
07/750,379 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent:
5,229,381 →
Application:
07/761,191 →
Synthesis of 4-Methyl Thiazole
Patent:
5,231,187 →
Application:
07/767,030 →
Angiotension Ii Antagonists in the Treatment of Hyperuricemia
Patent:
5,260,322 →
Application:
07/771,067 →
7-Chloroquinaldine Synthesis
Patent:
5,126,456 →
Application:
07/777,979 →
Method for the Purification of Intact, Correctly-Folded Insulin-Like Growth Factor-1
Patent:
5,231,178 →
Application:
07/785,171 →
Trialkylsilyl Trifluoromethanesulfonate Mediated Alpha-Methylenic Carbon Functionalization of 4-Aza-5ALPHA-Androstan-3-One Steroids
Patent:
5,187,278 →
Application:
07/786,615 →
Crystallization Method to Improve Crystal Structure and Size
Patent:
5,314,506 →
Application:
07/793,764 →
Child Resistant Unit Dose Package and Separate Drug Container
Patent:
5,163,559 →
Application:
07/810,254 →
Gene Encoding One Step Cephalosporin C Amidase and Exprission Thereof in Recombinant Bacillus
Patent:
5,229,274 →
Application:
07/819,717 →
Purified C5A Receptor from Human Polymorphonuclear Leukocytes
Patent:
5,177,190 →
Application:
07/825,435 →
Biosynthetic Production of 7-[1',2',6' ,7',8',8A'(R)- Hexahydro-2' <S>,6'<R>-Dimethyl-8'<S>-Hydroxy-1'<S>-Nap Hthyl]-3<R>,5(R)-Dihydroxyheptanoic Acid (Triol Acid)
Patent:
5,223,415 →
Application:
07/832,545 →
Novel Benzo-Fused Lactams That Promote the Release of Growth Hormone
Patent:
5,206,235 →
Application:
07/839,742 →
Sample Dissolution Chamber
Patent:
5,227,303 →
Application:
07/841,932 →
Automated Sterility Testing System with Concurrent Sample Dissolving,Diluting and Mixing
Patent:
5,213,967 →
Application:
07/841,933 →
Novel Process for the Preparation of 2-Diazo-3-Trisubstituted Silyloxy 3-Butenoates
Patent:
5,340,927 →
Application:
07/846,725 →
New Immunosuppressant-Producing Culture
Patent:
5,202,258 →
Application:
07/847,873 →
Alkylthio Alkyl Avermectins Are Active Antiparasitic Agents
Patent:
5,229,415 →
Application:
07/857,035 →
Stabilizers for Fibroblast Growth Factors
Patent:
5,348,941 →
Application:
07/861,060 →
Stable Salts of 4"-Deoxy-4"-Epi-Methylamino Avermectin Bla/Bib
Patent:
5,288,710 →
Application:
07/862,035 →
Preparation of Oxazaborolidine Borane Complex
Patent:
5,264,574 →
Application:
07/862,647 →
Fluorinated Hydroxyalkylquinoline Acids as Leukotriene Antagonists
Patent:
5,270,324 →
Application:
07/866,690 →
Avermectin Difluoro Derivatives
Patent:
5,229,416 →
Application:
07/875,486 →
Dna Encoding Glioma-Derived Growth Factor Having Vascular Endothelial Cell Growth Promoting Activity
Patent:
5,338,840 →
Application:
07/889,547 →
Process for Attenuated Varicella Zoster Virus Vaccine Production
Patent:
5,360,736 →
Application:
07/893,295 →
Process for Converting Lipid-Containing Bacterial Capsular Polysaccharide into Lipid-Free Polysaccharide
Patent:
5,314,811 →
Application:
07/909,346 →
High Speed Process for Preparing Orifices in Pharmaceutical Dosage Forms
Patent:
5,376,771 →
Application:
07/909,892 →
Imidazolidyl Macrolides Having Immunosuppressive Activity
Patent:
5,247,076 →
Application:
07/921,181 →
O-Heteroaryl, O-Alkylheteroaryl, O-Alkenylheteroaryl and O-Alkynylheteroarylmacrolides Having Immunosuppressive Activity
Patent:
5,252,732 →
Application:
07/921,851 →
Cysteine-Modified Acidic Fibroblast Growth Factor
Patent:
5,223,483 →
Application:
07/938,310 →
Angiotensin Ii Antagonist
Patent:
5,264,447 →
Application:
07/939,893 →
Angiotensin Ii Antagonist
Patent:
5,266,583 →
Application:
07/940,253 →
Method of Clonal Growth of Streptococcus Pneumoniae
Patent:
5,314,822 →
Application:
07/961,587 →
Acidic Derivatives of Homocysteine Thiolactone
Patent:
5,274,122 →
Application:
07/963,324 →
Chiral Catalysts for Reduction of Ketones and Process for Their Preparation
Patent:
5,264,585 →
Application:
07/966,658 →
Inhibitors of Hiv Reverse Transcriptase
Patent:
5,308,854 →
Application:
07/971,691 →
O-Arly, O-Alkyl, O-Alkenyl and O-Alkynylrapamycin Derivatives
Patent:
5,258,389 →
Application:
07/973,807 →
Novel Process for the Preparation of Benzylformimidate
Patent:
5,319,122 →
Application:
07/975,306 →
Dry Mix Formulation for Bisphosphonic Acids with Lactose
Patent:
5,358,941 →
Application:
07/984,399 →
Novel Benzo-Fused Lactams That Promote the Release of Growth Hormone
Patent:
5,310,737 →
Application:
08/012,190 →
Novel Process for the Preparation of Antiulcer Agents
Patent:
5,391,752 →
Application:
08/022,804 →
Production of Insulin-Like Growth Factor-1 in Methylotrophic Yeast Cells
Patent:
5,324,639 →
Application:
08/023,463 →
15-Substituted 4-Azasteroids
Patent:
5,359,071 →
Application:
08/030,508 →
Cysteine-Modified Acidic Fibroblast Growth Factor
Patent:
5,312,911 →
Application:
08/030,510 →
Antibiotic Agent
Patent:
5,366,880 →
Application:
08/066,282 →
Novel Spirocycles
Patent:
5,382,587 →
Application:
08/085,573 →
Genes Which Influence Pichia Proteolytic Activity, and Uses Therefor
Patent:
5,324,660 →
Application:
08/088,633 →
Controlled Release Drug Dispersion Delivery Device
Patent:
5,366,738 →
Application:
08/118,836 →
Process for the Preparation of 4"-Amino Avermectin Compounds
Patent:
5,362,863 →
Application:
08/128,936 →
Stable Solvates of Avermectin Compounds
Patent:
5,380,838 →
Application:
08/133,494 →
Neuronal Nicotinic Acetylcholihne Receptor Compositions
Patent:
6,136,550 →
Application:
08/349,956 →
Method of Treatment and Pharmaceutical Composition
Application:
09/117,343 →
Pharmaceutical Composition of a Tachykinin Receptor Antagonist
Mitotic Kinesin Inhibitors
Bicyclic Amides
Hepatitis C Virus Assay Systems
Ophthalmic compositions for treating ocular hypertension
Application:
10/511,636 →
Publication:
US 2005/0256117
Process for 5-[[2(R)-[1(R)-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3(S)-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-1,2-Dihydro-3H-1,2,4-Triazol-3-One
Piperidinyl-Alpha-Aminoamide Modulators of Chemokine Receptor Activity
Application:
10/528,293 →
Publication:
US 2005/0250814
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Methods and systems for identifying health care professionals with a prescribed attribute
Application:
11/046,174 →
Publication:
US 2005/0256738
Process for Making Lactam Tachykinin Receptor Antagonists
Application:
12/309,999 →
Publication:
US 2009/0247770
Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease
Application:
12/310,573 →
Publication:
US 2010/0298342
Liquid Pharmaceutical Formulations for Oral Administration of a Cgrp Antagonist
Application:
12/310,808 →
Method of Treatment Using Fatty Acid Synthesis Inhibitors
Piperidine and Pyrrolidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes
Application:
12/311,299 →
Publication:
US 2009/0239946
Amide Base Salts of Saha and Polymorphis Thereof
Application:
12/311,403 →
Publication:
US 2010/0035991
Substituted Imidazole as Bombesin Receptor Subtype-3 Modulators
Substituted Imidazoles as Bombesin Receptor Subtype-3 Modulators
Method for identifying modulators of the NRF2-KEAP1-ARE pathway
Application:
12/311,644 →
Publication:
US 2010/0029012
Substituted Imidazoles as Bombesin Receptor Subtype-3 Modulators
Antagonist Antibody of PCSK9
Application:
12/312,383 →
Publication:
US 2010/0040610
Antagonist Antibody of PCSK9
Application:
12/312,397 →
Publication:
US 2010/0136028
Antagonist Antibody of PCSK9
Application:
12/312,398 →
Publication:
US 2010/0040611
Antagonist Antibody of PCSK9
Application:
12/312,399 →
Publication:
US 2010/0150937
Antagonists of PCSK9
Application:
12/312,401 →
Publication:
US 2010/0041102
Inhibitor of Vascular Endothelial Cell Growth Factor
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Application:
12/364,902 →
Publication:
US 2009/0181994
Tyrosine Kinase Inhibitors
Application:
12/378,473 →
Publication:
US 2009/0186871
Substituted Amides
Pyrazole Derivatives, Compositions Containing Such Compounds and Methods of Use
Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use
Cgrp Receptor Antagonists
Soluble Guanylate Cyclase Activators
Application:
12/430,420 →
Publication:
US 2009/0209556
Difluorinated Piperidines for Treatment of Alzheimer's Disease and Related Conditions
Application:
12/439,010 →
Publication:
US 2010/0010041
Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted Amide
Application:
12/439,896 →
Publication:
US 2010/0209496
2-Hydroxy-2-Phenylthiophenylpropionamides as Androgen Receptor Modulators
Application:
12/442,581 →
Publication:
US 2009/0275515
Novel Inhibitors of Beta-Lactamase
Application:
12/442,816 →
Publication:
US 2010/0009957
Macrocyclic Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Application:
12/443,746 →
Publication:
US 2010/0004158
Non-Nucleoside Reverse Transcriptase Inhibitors
Application:
12/444,014 →
Publication:
US 2010/0113421
Hiv Integrase Inhibitors
Application:
12/445,594 →
Publication:
US 2010/0216834
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
Application:
12/445,704 →
Publication:
US 2010/0204278
Anti-Il-13R ALPHA1 Antibodies and Their Uses Thereof
Antibody Antagonists of Interleukin-13 Receptor ALPHA1
2-[1-Phenyl-5-Hydroxy or Methoxy-4ALPHA-Methyl-Hexahydrocyclopenta [F]Indazole-5-Yl]Ethyl Phenyl Derivatives as Glucocorticoid Receptor Ligands
Hcv NS3 Protease Inhibitors
Hcv NS3 Protease Inhibitors
Hcv NS3 Protease Inhibitors
Hcv NS3 Protease Inhibitors
Polymorphs of a Hydroisoindoline Tachykinin Receptor Antagonist
Application:
12/446,996 →
Publication:
US 2009/0270477
HCV NS3 Protease Inhibitors
Application:
12/447,342 →
Publication:
US 2010/0099695
Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Antifungal Agents
Method of Treating Atherosclerosis, dyslipidemias and related conditions
Application:
12/470,049 →
Publication:
US 2009/0233977
Crystal Structure of Human 70KD Ribosomal Protein S6 Kinase 1 Kinase Domain
Application:
12/481,103 →
Publication:
US 2009/0317850
P38 Kinase Inhibiting Agents
Solid Dosage Formulations of Telcagepant Potassium
Application:
12/493,311 →
Publication:
US 2010/0009967
Oxazole Derivatives Useful as Inhibitors of Faah
Application:
12/509,542 →
Publication:
US 2011/0021531
Cicletanine Derivatives
Heterocyclyl-Substituted Anti-Hypercholesterolemic Compounds
Application:
12/513,010 →
Publication:
US 2010/0069347
Tricyclic Heteroaromatic Compounds as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Acyl Bipiperidinyl Compounds Useful as Gpr 119 Agonists
Inhibitors of Akt Activity
Application:
12/517,492 →
Publication:
US 2010/0022573
Constrained Spirocyclic Compounds as Cgrp Receptor Antagonists
Substituted Diazepine Sulfonamides as Bombesin Receptor Subtype-3 Modulators
Spirochromanon Derivatives
Bipiperidinyl Compounds, Compositions Containing Such Compounds and Methods of Treatment
Application:
12/518,575 →
Publication:
US 2010/0029688
Anti-Hypercholesterolemic Compounds
Application:
12/518,771 →
Publication:
US 2010/0035857
Nucleoside Cyclic Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
Receptor for Amyloid Beta and Uses Thereof
Application:
12/519,249 →
Publication:
US 2010/0028333
Imidazopyridine Analogs as CB2 Receptor Modulators, Useful in the Treatment of Pain, Respiratory and Non-Respiratory Diseases
Application:
12/519,789 →
Publication:
US 2009/0325936
Silylated Piperidine Derivatives
Benzazepine Compounds as Cgrp Receptor Antagonists
Application:
12/520,146 →
Publication:
US 2012/0065190
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
Substituted Aminopyrimidines as Cholecystokinin-1 Receptor Modulators
Application:
12/521,648 →
Publication:
US 2010/0113492
Decahydroquinoline Analogs as CB2 Receptor Modulators, Useful in the Treatment of Pain, Respiratory and Non-Respiratory Diseases
Application:
12/523,192 →
Publication:
US 2010/0099673
Hiv Protease Inhibitors
Application:
12/523,200 →
Publication:
US 2010/0093811
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Epidermidis
Therapeutic Agents
Methods of Using SAHA for Treating HIV Infection
Application:
12/526,437 →
Publication:
US 2010/0324034
Piperidine Derivatives
Compositions and Methods for Potentiated Activity of Biologically Active Molecules
Application:
12/526,869 →
Publication:
US 2010/0015218
Formulations for Cathepsin K Inhibitors
Application:
12/527,876 →
Publication:
US 2009/0318560
Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers
Application:
12/528,041 →
Publication:
US 2010/0144715
Bipyridine Carboxamide Orexin Receptor Antagonists
Novel Crystalline Salt Form of an Antidiabetic Compound
In Vivo Hcv Resistance to Anti-Viral Inhibitors
Application:
12/529,785 →
Publication:
US 2010/0143886
Substituted Pyrido[2,3-D]Pyrimidine Derivatives as Cannabinoid-1 Receptor Modulators
Application:
12/529,852 →
Publication:
US 2010/0063032
Substituted Pyrido[3,2-E][1,2,4]Triazolo[4,3-C]Pyrimidine Derivatives as Cannabinoid-1 Receptor Modulators
Application:
12/529,889 →
Publication:
US 2010/0029697
Inhibitors of Janus Kinases and/or 3-Phosphoinositide-Dependent Protein Kinase-1
Monocyclic Anilide Spirolactam Cgrp Receptor Antagonists
Hexahydro-1H-4,7-Methanoisoindole-1,3-Dione Compounds
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Epidermidis
Application:
12/531,107 →
Publication:
US 2010/0104591
Mineralocorticoid Receptor Modulators
Combination Therapy for the Treatment-of Lower Urinary Tract Symptoms
Application:
12/532,731 →
Publication:
US 2010/0113469
Tripyridyl Carboxamide Orexin Receptor Antagonists
Aminoalkylphenols, Methods of Using and Making the Same
Cb-1 Receptor Modulator Pharmaceutical Formulations
Application:
12/558,977 →
Publication:
US 2010/0081642
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Hiv Integrase Inhibitors
Optimized Expression of Hpv 52 L1 in Yeast
Hydroxymethyl Ether Hydroisoindoline Tachykinin Receptor Antagonists
Method for Detecting Autoprocessed, Secreted PCSK9
Broadly Representative Antigen Sequences and Method for Selection
Application:
12/593,962 →
Publication:
US 2010/0183651
Novel 1.8-Naphthyridine Compounds
Application:
12/594,849 →
Publication:
US 2010/0056563
Isolated Nucleic Acid Molecules Corresponding to Micro Rna 145 (Mirna-145) and Their Use in Treating Colon Cancer
Application:
12/594,962 →
Publication:
US 2010/0113577
Aryl Heterocyclic Cgrp Receptor Antagonists
Bicyclic Anilide Heterocyclic Cgrp Receptor Antagonists
Crystalline Forms of Dihydropyrazolopyrimidinone
2-Substituted Indole Derivatives as Calcium Channel Blockers
Application:
12/597,081 →
Publication:
US 2010/0087446
Method of Treatment Using Fused Aromatic Compounds Having Anti-Diabetic Activity
Spiroindalones
ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
Application:
12/601,933 →
Publication:
US 2010/0166772
Carboxamide Heterocyclic Cgrp Receptor Antagonists
Tricyclic Anilide Heterocyclic Cgrp Receptor Antagonists
Formation of Tetra-Substituted Enamides and Stereoselective Reduction Thereof
Application:
12/603,901 →
Publication:
US 2010/0041893
Tyrosine Kinase Inhibitors
Substituted Monocyclic Cgrp Receptor Antagonists
Rna Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (Sina)
Application:
12/615,146 →
Publication:
US 2010/0145038
Inhibitors of Akt Activity
Method of Predicting the Probability of Modulation of Transcripts by Rnai Compounds
Application:
61/182,605 →
Segmented MicroRNA Mimetics
Application:
61/236,486 →
Assay Methods and Compositions Useful for Measuring the Transduction of an Intracellular Signal
Application:
90/005,326 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.